NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Nutriband Inc. Chairman Presentation at NobleCon21 Conference
TL;DR
Nutriband's conference presentation offers investors early insights into their abuse-deterrent fentanyl patch technology for potential market advantage.
Nutriband Chairman Serguei Melnik will present at NobleCon21 on December 3, with a webcast available the following day through nobleconference.com and Channelchek.com.
Nutriband's AVERSA technology prevents abuse of transdermal drugs, making medication safer for patients and communities worldwide.
Nutriband's innovative abuse-deterrent patch technology transforms how potent medications are delivered through the skin safely.
Found this article helpful?
Share it with your network and spread the knowledge!

Nutriband Inc. announced that Chairman and Co-Founder Serguei Melnik will present at the NobleCon21 emerging growth equity conference on December 3rd, providing investors with information about the company's developments.
The presentation is scheduled for December 3 at 9:30 a.m. Eastern time at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida.
A high-definition webcast will be available the day after the presentation at nobleconference.com and Channelchek.com, where it will remain archived for 90 days.
Nutriband is primarily engaged in developing transdermal pharmaceutical products, with their lead product being an abuse-deterrent fentanyl patch incorporating their AVERSA™ technology.
AVERSA™ is an abuse-deterrent technology that can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Yes, investors and guests may attend at a discounted rate using code NTRBNOBLECON.
The company's website is www.nutriband.com, and the latest news and updates relating to NTRB are available in the company's newsroom at https://nnw.fm/NTRB.
Serguei Melnik, the Chairman and Co-Founder of Nutriband Inc., will be presenting at the NobleCon21 conference.
NetworkNewsWire is a specialized communications platform that distributes financial news and content for companies and the investment community, and they are responsible for publishing this press release.
Curated from InvestorBrandNetwork (IBN)

